Advanced Electronic Data Capture Solution Helps Life Sciences Organizations
Conduct Trials More Efficiently and Effectively
BARCELONA, Spain, March 3 /PRNewswire-FirstCall/ -- DIA 20th ANNUAL EUROMEETING, Oracle today announced the introduction of Oracle(R) Remote Data Capture Onsite 4.5.3, the newest version of the company's electronic data capture (EDC) solution designed to help life sciences organizations and contract research organizations (CROs) conduct clinical trials and studies more effectively and efficiently. This significantly enhanced version of Oracle's EDC application features new functionality to meet the needs of trial sponsors as well as investigative site personnel. It is also completely Web based -- with zero client footprint for the HTML data entry window -- to enable improved global access and performance.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020718/ORCLLOGO)
Investigative sites are essential to the success of a clinical trial. The pharmaceutical industry is increasingly focused on providing investigative sites with tools that enable more rapid and accurate data entry. The most recent version of Oracle Remote Data Capture Onsite supports this requirement, providing new functionality, such as spreadsheet displays of multiple case books as well as robust edit check capabilities, intended to help busy investigative site personnel efficiently capture accurate data.
"Clinical trial sponsors are realizing considerable benefits from their
investment in EDC deployment; but the requirements of the investigator
site, EDC's most important end-users, historically have largely been left
unmet," said Chris Connor, senior research analyst at Health Industry
Insights, an IDC company. "Investigators are now pushing back on
sponsor-centric EDC solutions. The demands of patient care coupled with the
increasing responsibilities of
'/>"/>
| SOURCE Oracle Copyright©2008 PR Newswire. All rights reserved |